<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>bcr2015</ui>
   <ji>BCJ</ji>
   <fm>
      <dochead>Oral presentation</dochead>
      <bibl>
         <title>
            <p>Ultrasound-guided axillary node core biopsy in the staging of newly diagnosed breast cancer</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Britton</snm>
               <fnm>P</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Goud</snm>
               <fnm>A</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Barter</snm>
               <fnm>S</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A4">
               <snm>Eleti</snm>
               <fnm>A</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A5">
               <snm>Freeman</snm>
               <fnm>A</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A6">
               <snm>Gaskarth</snm>
               <fnm>M</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A7">
               <snm>Moyle</snm>
               <fnm>P</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A8">
               <snm>Rajan</snm>
               <fnm>P</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A9">
               <snm>Sinnatamby</snm>
               <fnm>R</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A10">
               <snm>Slattery</snm>
               <fnm>J</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A11">
               <snm>Provenzano</snm>
               <fnm>E</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A12">
               <snm>Pinder</snm>
               <fnm>S</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A13">
               <snm>Godward</snm>
               <fnm>S</fnm>
               <insr iid="I3"/>
            </au>
            <au id="A14">
               <snm>Wishart</snm>
               <fnm>G</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Cambridge Breast Unit, Cambridge, UK</p>
            </ins>
            <ins id="I2">
               <p>Department of Pathology, Guy's King's Thomas's Hospital London, UK</p>
            </ins>
            <ins id="I3">
               <p>Cambridgeshire Primary Care Trust, Cambridge, UK</p>
            </ins>
         </insg>
         <source>Breast Cancer Research</source>
         <supplement>
            <title>
               <p>Symposium Mammographicum 2008</p>
            </title>
            <note>Meeting abstracts</note>
            <url>http://breast-cancer-research.com/supplements/notes/BCR-vol10-suppl3-info.pdf</url>
         </supplement>
         <conference>
            <title>
               <p>Symposium Mammographicum 2008</p>
            </title>
            <location>Lille, France</location>
            <date-range>6&#8211;8 July 2008</date-range>
            <url>http://www.sympmamm.org.uk/</url>
         </conference>
         <issn>1465-5411</issn>
         <pubdate>2008</pubdate>
         <volume>10</volume>
         <issue>Suppl 3</issue>
         <fpage>P17</fpage>
         <url>http://breast-cancer-research.com/content/10/S3/P17</url>
         <xrefbib>
            <pubid idtype="doi">10.1186/bcr2015</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>7</day>
               <month>7</month>
               <year>2008</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2008</year>
         <collab>BioMed Central Ltd</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p/>
         </st>
         <p>One hundred and thirty-nine patients with core biopsy (CB)-proven unilateral primary operable invasive breast cancer underwent axillary ultrasound. Lymph nodes were identified on ultrasound in 134 patients (96%), of which 121 (87%) underwent core biopsy. The morphology of all biopsied nodes was noted. Normal lymph node was obtained in 77 CBs, 25 (32%) of which were subsequently shown to have nodal metastases. The results are presented in Table <tblr tid="T1">1</tblr>. The CB sensitivity for nodes with normal ultrasound morphology was 12%, for those with unilobulated cortex was 64%, for those with multilobulated cortex was 77%, for those with absent hilum was 88% and for those with multilobulated cortex and absent hilum was 100%.</p>
         <tbl id="T1">
            <title>
               <p>Table 1</p>
            </title>
            <caption>
               <p/>
            </caption>
            <tblbdy cols="2">
               <r>
                  <c ca="left">
                     <p>Number of axillas examined</p>
                  </c>
                  <c ca="center">
                     <p>139</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Number of axillas where nodes identified on ultrasound</p>
                  </c>
                  <c ca="center">
                     <p>134 (96%)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Number of axillas where CB performed</p>
                  </c>
                  <c ca="center">
                     <p>121 (87%)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>CB inadequate rate (%)</p>
                  </c>
                  <c ca="center">
                     <p>4.1</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Lymph node-positive (surgery) (%)</p>
                  </c>
                  <c ca="center">
                     <p>52.5</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>CB sensitivity, all positive nodes (%)</p>
                  </c>
                  <c ca="center">
                     <p>53.4</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>CB sensitivity, macrometastases (%)</p>
                  </c>
                  <c ca="center">
                     <p>62.3</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>CB sensitivity, micrometastases (%)</p>
                  </c>
                  <c ca="center">
                     <p>8.3</p>
                  </c>
               </r>
            </tblbdy>
         </tbl>
         <p>In conclusion, the present study shows that an aggressive CB policy leads to an increase in sensitivity, but of relatively modest proportions, and is at the expense of a large number of normal biopsies. CB is insensitive at detecting micrometastases. CB of nodes with a normal ultrasound morphology is of little utility.</p>
      </sec>
   </bdy>
</art>
